Zylox-Tonbridge
China - HangzhouBiotechnology
Focus: Zylox-Tonbridge is a public biotechnology company headquartered in Hangzhou, China, specializing in neurovascular devices with a focus on cardiovascular applications. The company operates as a medical device innovator in the high-growth peripheral vascular intervention market.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
0
About Zylox-Tonbridge
AI assessmentNot HiringNo open roles listed right now. Follow Zylox-Tonbridge to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
1 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Peripheral Drug-eluting Stent System
Peripheral Arterial DiseaseClinical Trials (1)
NCT07122167Post-market Registry Study on the Safety and Efficacy of ZENFLEX Pro™ Peripheral Drug-eluting Stent System for Femoropopliteal Artery Lesions
N/AHelp build intelligence for Zylox-Tonbridge
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.